Trial Details

RECRUITING
Basic Information
Clinical ID c335
Identifier NCT06117423
Trial Title Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohn Disease|Ulcerative Colitis
Interventions DRUG: Adalimumab-680LT|OTHER: Control
Participant Information
Sponsor University Medical Center Groningen
City Groningen
Country/Region Netherlands
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1|PHASE2
Time Information
Start Date 2025-03-24
Primary Completion Date 2025-12-24
Completion Date 2025-06-25